Tag: evolut

Two-year Evolut Low Risk trial data shows “very favourable outcomes” for TAVI compared with SAVR

 John Forrest (New Haven, USA) sits down with Cardiovascular News to talk about the full two-yea...

EuroPCR 2021: Two-year results of Evolut Low Risk trial “reassuring” for TAVI in low-risk patients

Complete two-year follow-up data from the Evolut Low Risk trial, presented during a late-breakin...

SCAI 2021: Interim OPTIMIZE PRO results point to benefit for cusp overlap TAVI technique

Medtronic has announced results from an interim analysis of the first 171 patients (including 71...

PCR e-Course 2020: Bicuspid TAVI is feasible, safe and efficient

The feasibility, safety, and efficiency of transcatheter aortic valve implantation (TAVI) using ...

EuroPCR 2017: Excellent clinical outcomes for Medtronic’s CoreValve and Evolut systems in routine practice

New positive data on the self-expanding Medtronic CoreValve platform from the CoreValve ADVANCE ...

Medtronic CoreValve Evolut becomes first TAVI to receive CE mark for intermediate risk aortic stenosis patients

Medtronic has received CE marking for the self-expanding, recapturable and repositionable CoreValv...